Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
4.490
+0.050 (1.13%)
At close: May 30, 2025, 4:00 PM
4.500
+0.010 (0.22%)
After-hours: May 30, 2025, 4:00 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $82.30 million as of May 30, 2025. Its market cap has increased by 14.48% in one year.
Market Cap
82.30M
Enterprise Value
69.21M
1-Year Change
14.48%
Ranking
Category
Stock Price
$4.49
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $82.30M, a decrease of -60.57%. That is a compound annual growth rate of -23.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 82.30M | 3.45% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |